|

Building
on Areas of Mutual Interest
At Inspire,
we are intent on providing medicines that make a difference in patients'
lives. We are interested in partnerships that balance
our product portfolio, complementing the line of products from our
own internal research efforts and augmenting our core therapeutic
areas of Ophthalmology and Respiratory/Allergy. Of particular interest
are:
Focused
Therapeutic Areas
Ophthalmology
Respiratory/Allergy
Highest
Priorities
Allergic Disease
Cystic Fibrosis
Glaucoma
Ocular Surface Disease
Technology Platforms
Latrunculin
B
Purinergic Receptor Agonists and Antagonists
Rho Kinase Inhibitors
For
in-licensing candidates, we are seeking compounds or products that
provide a meaningful benefit over currently existing treatments
either through novel mechanism of action, unique delivery mechanism,
improved efficacy, safety, quality of life or other significant
feature. We are particularly interested in therapies for specialty
therapeutic markets.
We
are seeking out-licensing partners for our cystic fibrosis and glaucoma
programs for markets outside of North America.
Page
last updated: 03-Jan-2008
|
|
|
|
|
|
Copyright
© 1999-2005 Inspire Pharmaceuticals Inc. All rights reserved
|
|
|
|